Cargando…

Decreasing ELK3 expression improves Bone Morphogenetic Protein Receptor 2 signaling and pulmonary vascular cell function in PAH

ELK3 is upregulated in blood and pulmonary vascular cells of PAH patients and may play a significant role in PAH potentially through modulating BMPR2 signaling.

Detalles Bibliográficos
Autores principales:	Ali, Md Khadem, Zhao, Lan, de Jesus Perez, Vinicio, Nicolls, Mark R., Spiekerkoetter, Edda F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882174/ https://www.ncbi.nlm.nih.gov/pubmed/36711443 http://dx.doi.org/10.1101/2023.01.14.524023

Ejemplares similares

Novel Advances in Modifying BMPR2 Signaling in PAH
por: Dannewitz Prosseda, Svenja, et al.
Publicado: (2020)

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Ali, Md Khadem, et al.
Publicado: (2023)

Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
por: Han, Yun, et al.
Publicado: (2021)

Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2020)

A case of recurrent pericardial constriction presenting with severe pulmonary hypertension
por: Brunner, Nathan W., et al.
Publicado: (2013)

Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
por: Amsallem, Myriam, et al.
Publicado: (2021)

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension
por: Rajmohan, Divya, et al.
Publicado: (2020)

Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathways
por: de Jesus Perez, Vinicio A., et al.
Publicado: (2009)

Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018)

Hiding in Plain Sight: The Basement Membrane in Pulmonary Vascular Remodeling
por: Chakraborty, Ananya, et al.
Publicado: (2020)

Bone morphogenetic protein-4 and bone morphogenetic protein receptors expressions in the adult rat eye
por: Maruyama-Koide, Yuka, et al.
Publicado: (2017)

Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor‐2: Involvement in HIV‐Associated Pulmonary Vascular Remodeling
por: Chinnappan, Mahendran, et al.
Publicado: (2018)

Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis
por: Meng, Zhaojie, et al.
Publicado: (2023)

Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
por: Bramlage, Carsten P, et al.
Publicado: (2010)

Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension
por: Caestecker, Mark De, et al.
Publicado: (2001)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

The biological function of type I receptors of bone morphogenetic protein in bone
por: Lin, Shuxian, et al.
Publicado: (2016)

Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor II gene and enhanced bone morphogenetic protein signaling: A case report
por: Choi, Sun Ha, et al.
Publicado: (2019)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Expression and regulation of bone morphogenetic protein antagonists in vascular smooth muscle cells
por: Maciel, TT, et al.
Publicado: (2003)

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)

Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein?
por: Epstein, Nancy E.
Publicado: (2014)

Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
por: Yang, Jun, et al.
Publicado: (2022)

Bone morphogenetic protein receptor signal transduction in human disease
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2018)

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Meng, Wangyang, et al.
Publicado: (2021)

The Classic: Bone Morphogenetic Protein
por: Urist, Marshall R., et al.
Publicado: (2009)

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines
por: Langenfeld, Elaine, et al.
Publicado: (2013)

Inhibition of bone morphogenetic protein 6 receptors ameliorates Sjögren’s syndrome in mice
por: Yin, Hongen, et al.
Publicado: (2020)

Role of Bone Morphogenetic Protein 4 in the Inflammation of the Myocardium and Vascular Tissue of Obese Mice
por: Wu, Ting, et al.
Publicado: (2022)

Repurposing of medications for pulmonary arterial hypertension
por: Toshner, Mark, et al.
Publicado: (2020)

Arteriovenous Malformations—Current Understanding of the Pathogenesis with Implications for Treatment
por: Schimmel, Katharina, et al.
Publicado: (2021)

Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification
por: Balderman, Joshua A. F., et al.
Publicado: (2012)

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation
por: Zhao, Ming, et al.
Publicado: (2002)

Bone Morphogenetic Protein Receptor in the Osteogenic Differentiation of Rat Bone Marrow Stromal Cells
por: Wang, Anxun, et al.
Publicado: (2010)

Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
por: Heinecke, Kai, et al.
Publicado: (2009)

Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma
por: Wang, Yongqing, et al.
Publicado: (2013)

Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension
por: De Gottardi, Andrea, et al.
Publicado: (2012)

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
por: Steele, Peter, et al.
Publicado: (2010)

Pathological characterization of TgElk mice injected with brain homogenate from elk with chronic wasting disease
por: Jeon, Yong-Chul, et al.
Publicado: (2013)

Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6p5m5i02pch3nv4tka743odr1l